A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans
Date
2012-12-31
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Abstract
Subthreshold posttraumatic stress disorder (PTSD) is associated with increased risk for suicidality, depression, and functional impairment. We thus conducted a small (N=12) pilot randomized controlled trial (RCT) with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) era veterans. Hospital Anxiety and Depression Scale (HADS) scores improved by 30.4% in the paroxetine group. Paroxetine may have promise for subthreshold PTSD.
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Naylor, Jennifer C, Trygve R Dolber, Jennifer L Strauss, Jason D Kilts, Timothy J Strauman, Daniel W Bradford, Steven T Szabo, Nagy A Youssef, et al. (2012). A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans. Psychiatry Research. 10.1016/j.psychres.2012.11.008 Retrieved from https://hdl.handle.net/10161/13846.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Jennifer C. Naylor
Jennifer Leigh Strauss
Jason David Kilts
Timothy J. Strauman
Professor Strauman's research focuses on the psychological and neurobiological processes that enable self-regulation, conceptualized in terms of a cognitive/motivational perspective, as well as the relation between self-regulation and affect. Particular areas of emphasis include: (1) conceptualizing self-regulation in terms of brain/behavior motivational systems; (2) the role of self-regulatory cognitive processes in vulnerability to depression and other disorders; (3) the impact of treatments for depression, such as psychotherapy and medication, on self-regulatory function and dysfunction in depression; (4) how normative and non-normative socialization patterns influence the development of self-regulatory systems; (5) the contributory roles of self-regulation, affect, and psychopathology in determining immunologically-mediated susceptibility to illness; (6) development of novel multi-component treatments for depression targeting self-regulatory dysfunction; (7) utilization of brain imaging techniques to test hypotheses concerning self-regulation, including the nature and function of hypothetical regulatory systems and characterizing the breakdowns in self-regulation that lead to and accompany depression.
Daniel William Bradford
Dr. Bradford's clinical and administrative work, research, and teaching is all in the area of mental health services for individuals with serious mental illnesses, particularly psychotic disorders. Since 2012, he has served as the National Director of Intensive Community Psychosocial Rehabilitation for the Department of Veterans Affairs in the Office of Mental Health. In this role, he is responsible for policy development and oversight of over 170 assertive community treatment-based clinical teams serving approximately 15,000 Veterans annually. In 2020, he was the primary author on the first VA national directive on early episode psychosis and currently co-leads this national initiative. In 2022, he accepted the additional role as the Director of the Psychotic Disorders Program at the VA National Expert Consultation and Specialized Services (NEXCSS) program. This program provides expert consultation evaluations and cognitive behavioral therapy for psychosis to veterans throughout the country.
In his clinical and administrative work at Durham VA Medical Center, he was the founding Division Chief for Psychosocial Rehabilitation and Recovery Services from 2014-2022. In prior years, he was also the founding Director of the Inteprofessional Fellowship for Psychosocial Rehabilitation and Recovery Services (2007-2012) and of the Psychosocial Rehabilitation and Recovery Services (2007-2014). He continues as a clinical psychiatrist and resident supervisor in the Division.
Dr. Bradford is board certified in Psychiatry by the American Board of Psychiatry and Neurology and in Addiction Medicine by the American Board of Preventive Medicine. He is a 2013 recipient of an Exemplary Psychiatrist Award from the National Alliance on Mental Illness (NAMI).
Christine Elizabeth Marx
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.